Insufficient scRNA-seq data for expression of FOXL2 at single-cell level.
Insufficient scRNA-seq data for expression of FOXL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 95% | 1223.38 | 161 / 170 | 69% | 5.91 | 317 / 459 |
ovary | 100% | 6048.76 | 180 / 180 | 52% | 4.62 | 224 / 430 |
brain | 91% | 42.55 | 2403 / 2642 | 40% | 0.72 | 280 / 705 |
adrenal gland | 100% | 341.24 | 257 / 258 | 26% | 2.94 | 59 / 230 |
prostate | 32% | 24.74 | 78 / 245 | 53% | 2.49 | 265 / 502 |
skin | 48% | 26.02 | 874 / 1809 | 20% | 0.99 | 94 / 472 |
pancreas | 44% | 9.89 | 144 / 328 | 10% | 0.39 | 17 / 178 |
esophagus | 11% | 2.98 | 166 / 1445 | 41% | 4.07 | 75 / 183 |
tonsil | 0% | 0 | 0 / 0 | 47% | 2.75 | 21 / 45 |
bladder | 0% | 0 | 0 / 21 | 30% | 1.66 | 149 / 504 |
lung | 1% | 0.17 | 3 / 578 | 26% | 2.05 | 295 / 1155 |
breast | 16% | 5.39 | 72 / 459 | 4% | 0.25 | 41 / 1118 |
blood vessel | 14% | 3.07 | 184 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 0.32 | 9 / 80 |
stomach | 0% | 0.56 | 1 / 359 | 8% | 0.37 | 22 / 286 |
thymus | 6% | 6.59 | 38 / 653 | 1% | 0.14 | 7 / 605 |
adipose | 6% | 2.22 | 72 / 1204 | 0% | 0 | 0 / 0 |
intestine | 2% | 0.63 | 16 / 966 | 3% | 0.09 | 15 / 527 |
liver | 0% | 1.02 | 1 / 226 | 4% | 0.12 | 15 / 406 |
kidney | 1% | 0.15 | 1 / 89 | 1% | 0.04 | 12 / 901 |
muscle | 1% | 0.27 | 10 / 803 | 0% | 0 | 0 / 0 |
heart | 1% | 0.10 | 5 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.03 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060014 | Biological process | granulosa cell differentiation |
GO_0001541 | Biological process | ovarian follicle development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0002074 | Biological process | extraocular skeletal muscle development |
GO_0019101 | Biological process | female somatic sex determination |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0001555 | Biological process | oocyte growth |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_0060065 | Biological process | uterus development |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0033686 | Biological process | positive regulation of luteinizing hormone secretion |
GO_0046881 | Biological process | positive regulation of follicle-stimulating hormone secretion |
GO_0006309 | Biological process | apoptotic DNA fragmentation |
GO_0007338 | Biological process | single fertilization |
GO_0048048 | Biological process | embryonic eye morphogenesis |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090543 | Cellular component | Flemming body |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0043028 | Molecular function | cysteine-type endopeptidase regulator activity involved in apoptotic process |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FOXL2 |
Protein name | Forkhead box protein L2 Forkhead box L2 |
Synonyms | |
Description | FUNCTION: Transcriptional regulator. Critical factor essential for ovary differentiation and maintenance, and repression of the genetic program for somatic testis determination. Prevents trans-differentiation of ovary to testis through transcriptional repression of the Sertoli cell-promoting gene SOX9 (By similarity). Has apoptotic activity in ovarian cells. Suppresses ESR1-mediated transcription of PTGS2/COX2 stimulated by tamoxifen (By similarity). Is a regulator of CYP19 expression (By similarity). Participates in SMAD3-dependent transcription of FST via the intronic SMAD-binding element (By similarity). Is a transcriptional repressor of STAR. Activates SIRT1 transcription under cellular stress conditions. Activates transcription of OSR2. . |
Accessions | A0A8B0T273 A0A8B0SXM7 Q4JHB5 Q53ZD3 A0A8B0SX55 ENST00000648323.1 A0A8B0SWN0 A0A8B0SXZ5 A0A8B0SXP0 A0A8B0SX42 A0A8B0SY07 Q4JHB6 A0A8B0T278 Q05CX9 A0A8B0SUP7 A0AA96HC68 P58012 A0A8B0T146 A0A8B0SY93 A0A8B0SWK9 A0A8B0T069 Q4JHB7 A0A8B0SUS0 |